期刊文献+

p53,bcl-2,caspase-3在老年晚期非小细胞肺癌组织中的表达及对预后的影响 被引量:5

Expression of p53,bcl-2,caspase-3 and effect on prognosis in tissues of elderly patients with advanced NSCLC
下载PDF
导出
摘要 目的探讨p53、bcl-2、caspase-3在117例老年晚期非小细胞肺癌组织中的表达与预后的关系。方法收集经手术后病理学检查确诊的117例老年晚期NSCLC患者的临床资料和存档石蜡组织标本。免疫组织化学方法检测肿瘤组织中p53、bcl-2、caspase-3蛋白的表达情况,分析p53、bcl-2、caspase-3蛋白表达的相关性,及其与患者临床病理学特征、与预后之间的关系。结果 NSCLC组织中bcl-2与caspase-3表达成显著正相关(r=0.262,P=0.003)。117例老年晚期NSCLC组织标本中,p53、bcl-2、caspase-3的阳性表达率分别为42.74%(50/117)、38.46%(45/117)、36.75%(43/117)。p53阳性表达率在低分化、中央型、有淋巴结转移的鳞癌患者中较高(P<0.05);bcl-2阳性表达率在高分化、有淋巴结转移患者中较高(P<0.05);caspase-3阳性表达率在高分化、无淋巴结转移患者中较高(P<0.05)。非小细胞肺癌组织中p53、bcl-2表达阳性的患者2年生存率显著低于表达阴性的患者(P<0.05);而非小细胞肺癌组织中caspase-3表达阳性的患者2年生存率与表达阴性的患者之间无明显差异(P>0.05)。结论 p53、bcl-2、caspase-3可能在老年晚期NSCLC的发生和发展过程中起重要调控作用,可作为判断老年晚期NSCLC患者预后的参考指标。 Objective To investigate the expression of p53, bcl-2 and caspase-3 in tissues of 117 elderly patients with advanced non-small cell lung cancer (NSCLC), and explore its clinical significance. Methods The clinical data and paraffin tissue samples of 117 patients with NSCLC confirmed by postoperative pathology were collected. The expression of p53, bcl-2 and caspase-3 protein in tissues of NSCLC was detected by immunohistochemical method, the correlation among the expression of p53, bcl-2 and caspase-3 protein was analyzed, and the relationship between the expression of p53, bcl-2 and caspase-3 protein and clinicopathological characteristics or between the expression of p53, bcl-2 and caspase-3 protein and survival was explored. Results The expression of bcl-2 was significantly positively related to that of caspase-3 in tissues of NSCLC (r=0.262, P=0.003). The positive expression rates of p53, bcl-2, caspase-3 in tissues of NSCLC were 42.74% (50/117), 38.46% (45/117), 36.75% (43/117), respectively in 117 patients. Patients with poor differentiation, central type, lymph node metastasis and squamous carcinoma had higher positive expression rates of p53. High differentiation, lymph node metastasis had higher expression rates of bcl -2, and high differentiation, no lymph node metastasis had higher positive expression rates of caspase-3. The 2-year survival rates of patients with positive expression of p53 and bcl-2 in tissues of NSCLC were significantly lower than those with negative expression (P〈 0.05). The 2-year survival rates of patients with positive expression of caspase-3 in tissues of NSCLC were not significantly dif-ferent than those with negative expression (P〈 0.05). Conclusion The p53, bcl-2 and caspase-3 may play important roles in the development and progression of elderly patients with advanced NSCLC, and may serve as predicators for prognosis.
出处 《北京医学》 CAS 2014年第7期581-585,共5页 Beijing Medical Journal
关键词 P53 BCL-2 CASPASE-3 老年患者 非小细胞肺癌 p53 bcl-2 caspase-3 Elderly patient Non-small cell lung cancer(NSCLC)
  • 相关文献

参考文献23

  • 1Dela Cruz CS, Tanoue LT, Matthay RA, et al. Lung cancer: epi- demiology, etiology, and prevention [J]. Clin Chest Med, 2011, 32:605-644.
  • 2Gao Q, Yang S, Kang MQ. Influence of survivin and Bcl-2 ex- pression on the biological behavior of non-small cell lung cancer [J]. Molecular Medicine Reports, 2012, 5:1409-1414.
  • 3Jemal A, Siegel R, Ward E, et al. Cancer statistics [J]. CA Cancer J Clin, 2008, 58:71-96.
  • 4刘翼,阿迪力,陆艳荣,张国庆,庞作良.Ⅲ_A(N_2)期非小细胞肺癌术后放疗疗效分析[J].中国癌症杂志,2013,23(6):452-456. 被引量:16
  • 5沈晓咏,吕帆真,武韫,赵丽婷.bcl-2,bax和p53在小细胞肺癌中的表达及对细胞凋亡的影响[J].四川医学,2013,34(7):915-917. 被引量:16
  • 6叶飞,周国忠,倪铁钧,杨明锋,沈巨兴,秦娥.HnRNP A_2/B_1和P_(53)蛋白对肺癌诊断价值的探讨[J].放射免疫学杂志,2008,21(1):86-88. 被引量:3
  • 7Mitsudomi T, Takahashi T. Genetic abnormalities in lung cancer and their prognostic implications [J]. Jap J Cancer Chemother (Gan To Kagaku Ryoho), 1996, 23:990-996.
  • 8Gessner C, Kuhn N, Toepfer K, et al. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients [J]. Lung Cancer, 2004, 43:215-222.
  • 9Xiao G, Fang H, Xing C, et al. Structure, function and inhibitionof Bcl-2 family proteins: a new target for anti-tumor agents [J]. Mini Rev Med Chem, 2009, 9:1596-1604.
  • 10邓亮,吴娣,洪一江,毛慧玲.BCL-2家族的研究新进展[J].安徽农业科学,2012,40(4):1936-1938. 被引量:14

二级参考文献71

共引文献77

同被引文献44

  • 1王鹏,庞新.低分子肝素对人乳腺癌细胞增殖抑制作用及其机制研究[J].中国医药导刊,2013,15(S1):175-176. 被引量:3
  • 2李小江,贾英杰.非小细胞肺癌生存分析[J].天津中医药,2013,30(9):531-533. 被引量:7
  • 3Barr MP, Gray SG, Hoffmann AC, et al. Generation and char- acterization of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature [J]. PLoS One, 2013,8 (1):1-19.
  • 4Gartel AL, Kandel ES. RNA interference in cancer [J]. Biomol Eng, 2006,23( 1 ) : 17-34.
  • 5Wang Y, Tao ZZ, Chen SM, et al. Application of combination of short hairpin RNA segments for silencing VEGF, TERT and Bcl-xl expression in laryngeal squamous carcinoma [J]. Cancer Biol Ther, 2008,7(6) : 896-901.
  • 6Orelli B, McClendon TB, Tsodikov OV, et al. The XPA-bind- ing domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways [J]. J Biol Chem, 2010, 285(6) :3705-3712.
  • 7Li J, Li ZN, Yu LC, et al. Association of expression of MRP1, BCRP, LRP and ERCCI with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy [J]. Lung cancer, 2010,69( 1 ) : 116-122.
  • 8Losert D, Pratscher B, Soutschek J, et al. Bcl-2 downregula- tion sensitizes nonsmall cell lung cancer ceils to cisplatin, but not to docetaxel [J]. Anticancer Drug, 2007,18 (7):755- 761.
  • 9Kawatani M, Imoto M. Deletion of the BH1 domain of Bcl-2 ac- celerates apoptosis by acting in a dominant negative fashion [ J ]. J Biol Chem, 2003,278 (22) : 19732-19742.
  • 10彭鹏,郑莹,王杰军,顾凯,黄哲宙,王春芳,鲍萍萍,向咏梅,龚杨明,吴春晓.癌痛患者的生活质量及其影响因素研究[J].中国肿瘤,2009,18(4):273-277. 被引量:75

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部